Differentially expressed long noncoding RNAs and regulatory mechanism of LINC02407 in human gastric adenocarcinoma

Table 1 Top 20 upregulated and top 20 downregulated long noncoding RNAs involved in gastric cancer

LncRNA (up-regulated)	Log FC	-LogFDR	LncRNA (down-regulated)	Log FC	-LogFDR
MAGEA4-AS1	8.20	6.39	HCG22	-4.59	30.13
LINC02582	7.29	7.04	LINC00955	-3.87	16.19
LINC00392	6.98	5.23	PGM5-AS1	-3.75	25.23
HOXC-AS3	6.91	17.67	IL12A-AS1	-3.31	38.15
DSCR8	6.78	6.14	C5orf66-AS1	-3.19	22.45
LINC02474	6.76	9.65	PCAT18	-3.15	17.08
TMEM132D-AS1	6.67	6.35	LINC02404	-3.11	10.98
LINC01234	6.55	14.68	UBXN10-AS1	-3.07	30.68
LINC01980	6.49	7.77	LINC02560	-3.06	13.89
BANCR	6.21	7.50	LRRC3-DT	-3.01	22.82
ERVMER61-1	6.17	5.87	LINC01697	-2.99	24.83
LINC02163	5.90	17.22	HAND2-AS1	-2.96	14.27
DSCR4	5.75	5.33	LINC00330	-2.91	13.05
LINC01050	5.75	16.19	MIR205HG	-2.86	4.34
LINC00973	5.72	4.97	CERS3-AS1	-2.82	15.20
LINC01419	5.72	6.63	LINC02487	-2.81	16.19
HOTAIR	5.55	17.76	LINC02106	-2.70	16.69
LINC01287	5.48	6.53	LINC00671	-2.69	21.70
OVAAL	5.44	4.37	ADAMTS9-AS1	-2.66	29.85
LINC01194	5.36	5.12	MIR1-1HG-AS1	-2.64	12.84

LncRNAs: Long noncoding RNAs; FC: Fold change; FDR: False discovery rate.

Table 2 Survival analysis of differentially expressed long noncoding RNAs

Gene	HR	Z value	P value
FLJ16779	1.16	3.48	4.93E-04
LINC01537	1.25	3.46	5.34E-04
LINC02407	1.28	3.41	6.49E-04
LINC00565	1.21	3.18	1.46E-03
ADAMTS9-AS1	1.18	2.99	2.81E-03
LINC02408	1.20	2.98	2.90E-03
LINC01614	1.13	2.93	3.35E-03
RNF144A-AS1	1.21	2.93	3.40E-03
MAGI2-AS3	1.23	2.87	4.09E-03
CYMP-AS1	1.13	2.86	4.18E-03
PTPRD-AS1	1.16	2.86	4.27E-03
APCDD1L-DT	1.18	2.84	4.56E-03
C15orf54	1.18	2.83	4.68E-03
LINC00973	1.12	2.72	6.49E-03

HR: Hazard ratio.